Company Filing History:
Years Active: 1998-1999
Title: Dirk Klaas Meijer: Innovator in Pharmaceutical Science
Introduction
Dirk Klaas Meijer is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of pharmaceutical science, particularly in the development of modified proteins for medical applications. With a total of 2 patents, his work focuses on innovative solutions for treating viral infections.
Latest Patents
One of his latest patents is titled "Modified proteins and their use for controlling viral infections." This invention relates to pharmaceutical preparations designed to treat viral infections, including influenza and immunodeficiency diseases. The preparations utilize modified proteins or polypeptides that have acquired an additional net negative charge through derivatization with aconitic acid. This modification prevents the protonation of basic amino acids, enhancing the efficacy of the treatment. Another significant patent is "Pharmaceutical composition having site-specific delivery," which further showcases his expertise in creating targeted therapeutic solutions.
Career Highlights
Dirk Klaas Meijer has worked with prestigious institutions such as Rijksuniversiteit Groningen and Rijksuniversiteit Te Groningen. His research has contributed to advancements in the pharmaceutical industry, particularly in the area of viral infection control. His innovative approaches have garnered attention and respect within the scientific community.
Collaborations
Throughout his career, Meijer has collaborated with esteemed colleagues, including Erik J. Franssen and Frits Moolenaar. These partnerships have facilitated the exchange of ideas and fostered advancements in their respective fields.
Conclusion
Dirk Klaas Meijer stands out as an influential inventor in the realm of pharmaceutical science. His innovative patents and collaborations reflect his commitment to advancing medical treatments for viral infections. His work continues to inspire future research and development in this critical area of healthcare.